相关实验视频
Updated: Jun 9, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
由雄激素受体向的PYGB有助于瘤进展和代谢重编程在食道状癌的食道状癌
Huikai Miao1, Chunmei Xu2, Wuyou Gao3
1Institute of Pharmaceutical Research, Shandong Key Laboratory of Digital Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China; Department of Thoracic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; Department of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
雄激素受体 (AR) 驱动食道状细胞癌 (ESCC) 在男性的进展通过调节糖原酸化酶B (PYGB),一个关键的代谢酶. 准PYGB为ESCC治疗提供了新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 食道状细胞癌 (ESCC) 在男性中表现出更高的发病率和死亡率.
- 雄激素受体 (AR) 涉及男性特征和瘤进展,但其在ESCC中的作用尚不清楚.
研究的目的:
- 研究AR在ESCC中的作用及其与葡萄糖代谢酶的关系.
- 阐明AR介导的代谢重编程对ESCC进展的功能影响.
主要方法:
- 免疫组织化学评估AR和ESCC组织中的葡萄糖代谢酶表达.
- 染色体免疫沉降和光酶测试以确定AR基因促进物相互作用.
- 多omics测序,细胞增殖,迁移,入侵和代谢分析,以及异种移植模型.
主要成果:
- 在男性ESCC组织中,AR表达显著更高.
- 糖原酸化酶B (PYGB) 表达与AR正相关,并预测预后不佳.
- AR直接上调PYGB,促进ESCC细胞的增殖,入侵,转移和改变代谢.
结论:
- PYGB是一个直接的AR目标,对ESCC进展和代谢重编程至关重要.
- 针对AR-PYGB轴为ESCC提供了一个潜在的治疗策略.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
相关概念视频
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...